Preclinical and Clinical Evaluation of Epratuzumab (Anti-Cd22 IgG) in B-Cell Malignancies

Oncogene - United Kingdom
doi 10.1038/sj.onc.1210370
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Therapy of Advanced B-Lymphoma Xenografts With a Combination of 90y-Anti-Cd22 IgG (Epratuzumab) and Unlabeled Anti-Cd20 IgG (Veltuzumab)

Clinical Cancer Research
Cancer ResearchOncology
2008English

Anti-Cd22 Immunotoxin RFB4(dsFv)-PE38 (BL22) for CD22-Positive Hematologic Malignancies of Childhood: Preclinical Studies and Phase I Clinical Trial

Clinical Cancer Research
Cancer ResearchOncology
2010English

Epratuzumab Targeting of CD22 Affects Adhesion Molecule Expression and Migration of B-Cells in Systemic Lupus Erythematosus

Arthritis Research and Therapy
RheumatologyAllergyImmunology
2010English

Efficacy of an Anti-Cd22 Antibody-Monomethyl Auristatin E Conjugate in a Preclinical Xenograft Model of Precursor B-Cell Acute Lymphoblastic Leukemia

Leukemia and Lymphoma
Cancer ResearchOncologyHematology
2016English

Preclinical Evaluation of UAB30 in Pediatric Renal and Hepatic Malignancies

Molecular Cancer Therapeutics
Cancer ResearchOncology
2016English

Design, Development, Characterization and Testing of CD22 Targeted Long Circulating Liposomal Drug Delivery Systems for B Cell Malignancies

English

Targeting of B-Cell Receptor Signalling in B-Cell Malignancies

Journal of Internal Medicine
Internal Medicine
2017English

Radioimmunotherapy for Model B Cell Malignancies Using 90y-Labeled Anti-Cd19 and Anti-Cd20 Monoclonal Antibodies

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2002English

Targeting B-Cell Malignancies With the Beta-Emitting Anti-Cd37 Radioimmunoconjugate 177Lu-Nnv003

European Journal of Nuclear Medicine and Molecular Imaging
MedicineNuclear MedicineRadiologyImaging
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy